The figure shows a typical standard curve for the human Sclerostin ELISA. The immunoassay is calibrated against human recombinant Sclerostin peptide.
The figure shows a typical standard curve for the human Sclerostin ELISA. The immunoassay is calibrated against human recombinant Sclerostin peptide.
Human Sclerostin ELISA
BI-20492
Assay Sample TypeSerum, EDTA plasma, citrate plasma, heparın plasma, urine, cell culture supernatant
Product group Assays
Overview
- SupplierBiomedica
- Product NameHuman Sclerostin ELISA
- Delivery Days Customer7
- Assay Detection Range0 – 240 pmol/l (= 0 – 5,400 pg/ml)
- Assay PrecisionIn-between-run (n=6): ≤ 10 % CV. Within-run (n=8): ≤ 7 % CV
- Assay Sample TypeSerum, EDTA plasma, citrate plasma, heparın plasma, urine, cell culture supernatant
- Assay Sensitivity3.2 pmol/l (= 72 pg/ml)
- Assay SpecificityEndogenous and recombinant human Sclerostin.
- Assay Test PrincipleThe Sclerostin ELISA kit is a sandwich enzyme immunoassay for the quantitative determination of Sclerostin (SOST) in human serum, plasma, urine and cell culture supernatnat samples.
- Assay Time18-24 h / 1 h / 30 min
- CertificationResearch Use Only
- Scientific DescriptionThe human Sclerostin ELISA kit is an overnight, 96-well sandwich ELISA for the quantitative determination of human Sclerostin in serum, plasma, urine and cell culture supernatant. The Sclerostin ELISA employs human serum-based standards to ensure the measurement of biologically reliable data. The Sclerostin ELISA assay uses highly purified, epitope mapped antibodies.
- UNSPSC41116133
References
- Maïmoun L, Gelis A, Serrand C, et al. Whole-body vibration may not affect bone mineral density and bone turnover in persons with chronic spinal cord injury: A preliminary study. J Spinal Cord Med. Published online November 6, 2023:1-13.Read more